FDA Requires Updates to Prescribing Information for All Opioid Pain Medication
- Food and Drug Administration
- All Healthcare Organizations
The U.S. Food and Drug Administration (FDA) has announced several required updates to the prescribing information for both immediate-release (IR) and extended release/long acting (ER/LA) opioid pain medicines. This includes stating for all opioid pain that the risk of overdose increases as the dose increases.
- The updates to IR opioids state these products should not be used for an extended period unless the pain remains severe enough to require them and alternative treatments continue to b…